This Solicitation opportunity from Department Of Defense was posted on May 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BENZOCAINE ORAL TOP
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract solicitation SPE2DP-26-T-3376 is for the procurement of 1 unit of Benzocaine Oral Topical Gel, 20%, in a 1 oz (28g) container, identified by NSN 6505010645769 and manufacturer part number NDC00283-0871-31. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months and must be packaged in commercial-grade sealed unit containers that protect against damage, with exterior shipping containers suitable for safe delivery via common carrier at the lowest cost to the designated destination in Asheville, NC. Packaging, preservation, and marking must fully comply with MIL-STD-2073-1E and the Medical Marking Standard No. 1 (MMS NO. 1), which supersedes MIL-STD-129 except for items containing radioactive materials above threshold levels. All items must be labeled in accordance with OSHA’s Hazard Communication Standard, and hazardous material documentation must be submitted pre-award. Delivery is required within 20 days of award, with FOB Destination terms, and inspection and acceptance occur at the point of delivery by government personnel. The contract is governed by simplified acquisition procedures under FAR 52.213-4 and includes clauses addressing equal opportunity, trafficking prevention, employment eligibility verification, sustainable products, hazardous materials, and cybersecurity compliance. Contractors must be registered in SAM with a valid UEI and CAGE code, and must complete representations regarding small business status and socioeconomic designations. Cybersecurity requirements mandate compliance with NIST SP 800-171 Revision 1, including submission of assessment scores to the Supplier Performance Risk System and adherence to safeguarding and incident reporting obligations. The solicitation is issued by the Defense Logistics Agency’s Medical Supply Chain Pharm FSA, with proposals due by May 18, 2026, via the DIBBS electronic system. The contract type remains unspecified at solicitation stage but is likely to be fixed-price, and payment will be processed exclusively through WAWF. Hazardous materials labeling compliance and cybersecurity attestations are critical contractual obligations with no waiver or flexibility permitted.
General Info
Agency
NAICS
Place of Performance
100 MINUTEMAN DR, ASHEVILLE, NC, 28806-0000, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
BENZOCAINE ORAL TOPICAL GEL, 20%,1 OZ or (28G) RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
U/I "BT"
INCLUDE ZX001 OBJECT TEXT ID ST
1 BT = 28 GM
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
BEUTLICH PHARMACEUTICALS, LLC 34547 P/N NDC00283-0871-31
SPE2DP-26-T-3376
SECTION B
PR: 7016723703 PRLI: 0001 CONT’D
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016723703 0001 BT 1.000
NSN/MATERIAL:6505010645769
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-064-5769 Quantity: 1 BT Purchase Request: 7016723703QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS